Royalty Pharma plc (RPRX): Share Repurchases
$1.23B
Year ended 2025-12-31
$321.77M
Trailing 12 months to 2026-06-30
| Period ended | Share Repurchases | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.23B | +434.5% | 2026-02-11, From 2025-01-01 |
| 2024-12-31 | $229.65M | -24.6% | 2026-02-11, From 2024-01-01 |
| 2023-12-31 | $304.76M | n/a | 2026-02-11, From 2023-01-01 |
| 2022-12-31 | $0 | n/a | 2025-02-12, From 2022-01-01 |
| 2021-12-31 | $0 | n/a | 2024-02-15, From 2021-01-01 |
| 2020-12-31 | $0 | -100.0% | 2022-02-15, From 2020-01-01 |
| 2019-12-31 | $4.27M | n/a | 2022-02-15, From 2019-01-01 |
| 2018-12-31 | $0 | n/a | 2021-02-24, From 2018-01-01 |
Share Repurchases at similar companies
| Company | Year ended | Share Repurchases | Change YoY |
|---|---|---|---|
| Royalty Pharma plc (RPRX) | 2025-12-31 | $1.23B | +434.5% |
| Sarepta Therapeutics, Inc. (SRPT) | 2025-12-31 | $25.01M | n/a |
| United Therapeutics Corp (UTHR) | 2025-12-31 | $1.00B | 0.0% |
| Alkermes plc. (ALKS) | 2024-12-31 | $200.28M | n/a |
| Jazz Pharmaceuticals plc (JAZZ) | 2025-12-31 | $125.02M | -59.9% |
| Indivior Pharmaceuticals, Inc. (INDV) | 2025-12-31 | $11.00M | -93.6% |
| Prestige Consumer Healthcare Inc. (PBH) | 2026-03-31 | $156.28M | +203.4% |
| ANI Pharmaceuticals Inc (ANIP) | 2025-12-31 | $12.21M | +11.4% |
| Collegium Pharmaceutical, Inc (COLL) | 2025-12-31 | $25.10M | -58.2% |
Compare RPRX, SRPT, UTHR, ALKS side by side · Screen every company in Pharmaceutical Preparations ↗